3-30800968-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_207359.3(GADL1):c.1171T>C(p.Phe391Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0000638 in 1,613,882 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_207359.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GADL1 | NM_207359.3 | c.1171T>C | p.Phe391Leu | missense_variant | Exon 12 of 15 | ENST00000282538.10 | NP_997242.2 | |
GADL1 | XM_017006297.2 | c.1114T>C | p.Phe372Leu | missense_variant | Exon 12 of 15 | XP_016861786.1 | ||
GADL1 | XM_047448071.1 | c.1171T>C | p.Phe391Leu | missense_variant | Exon 12 of 14 | XP_047304027.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GADL1 | ENST00000282538.10 | c.1171T>C | p.Phe391Leu | missense_variant | Exon 12 of 15 | 5 | NM_207359.3 | ENSP00000282538.5 | ||
GADL1 | ENST00000454381.3 | c.1171T>C | p.Phe391Leu | missense_variant | Exon 12 of 12 | 1 | ENSP00000427059.1 |
Frequencies
GnomAD3 genomes AF: 0.000342 AC: 52AN: 152138Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000756 AC: 19AN: 251346Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135848
GnomAD4 exome AF: 0.0000349 AC: 51AN: 1461626Hom.: 0 Cov.: 34 AF XY: 0.0000316 AC XY: 23AN XY: 727112
GnomAD4 genome AF: 0.000342 AC: 52AN: 152256Hom.: 0 Cov.: 31 AF XY: 0.000349 AC XY: 26AN XY: 74456
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1171T>C (p.F391L) alteration is located in exon 12 (coding exon 12) of the GADL1 gene. This alteration results from a T to C substitution at nucleotide position 1171, causing the phenylalanine (F) at amino acid position 391 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at